Antimicrobial  ||| S:0 E:14 ||| JJ
compounds  ||| S:14 E:24 ||| NN
from  ||| S:24 E:29 ||| IN
seaweeds-associated  ||| S:29 E:49 ||| JJ
bacteria  ||| S:49 E:58 ||| NNS
and  ||| S:58 E:62 ||| CC
fungi  ||| S:62 E:68 ||| NNS
In  ||| S:68 E:71 ||| IN
recent  ||| S:71 E:78 ||| JJ
decade ||| S:78 E:84 ||| NN
,  ||| S:84 E:86 ||| ,
seaweeds-associated  ||| S:86 E:106 ||| JJ
microbial  ||| S:106 E:116 ||| JJ
communities  ||| S:116 E:128 ||| NNS
have  ||| S:128 E:133 ||| VBP
been  ||| S:133 E:138 ||| VBN
significantly  ||| S:138 E:152 ||| RB
evaluated  ||| S:152 E:162 ||| VBN
for  ||| S:162 E:166 ||| IN
functional  ||| S:166 E:177 ||| NN
and  ||| S:177 E:181 ||| CC
chemical  ||| S:181 E:190 ||| JJ
analyses ||| S:190 E:198 ||| NNS
.  ||| S:198 E:200 ||| .
Such  ||| S:200 E:205 ||| JJ
analyses  ||| S:205 E:214 ||| NNS
let  ||| S:214 E:218 ||| VBP
to  ||| S:218 E:221 ||| TO
conclude  ||| S:221 E:230 ||| VB
that  ||| S:230 E:235 ||| DT
seaweeds-associated  ||| S:235 E:255 ||| JJ
microbial  ||| S:255 E:265 ||| JJ
communities  ||| S:265 E:277 ||| NNS
are  ||| S:277 E:281 ||| VBP
highly  ||| S:281 E:288 ||| RB
diverse  ||| S:288 E:296 ||| JJ
and  ||| S:296 E:300 ||| CC
rich  ||| S:300 E:305 ||| JJ
sources  ||| S:305 E:313 ||| NNS
of  ||| S:313 E:316 ||| IN
bioactive  ||| S:316 E:326 ||| JJ
compounds  ||| S:326 E:336 ||| NN
of  ||| S:336 E:339 ||| IN
exceptional  ||| S:339 E:351 ||| JJ
molecular  ||| S:351 E:361 ||| JJ
structure ||| S:361 E:370 ||| NN
.  ||| S:370 E:372 ||| .
Extracting  ||| S:372 E:383 ||| VBG
bioactive  ||| S:383 E:393 ||| JJ
compounds  ||| S:393 E:403 ||| NN
from  ||| S:403 E:408 ||| IN
seaweed-associated  ||| S:408 E:427 ||| JJ
microbial  ||| S:427 E:437 ||| JJ
communities  ||| S:437 E:449 ||| NNS
have  ||| S:449 E:454 ||| VBP
been  ||| S:454 E:459 ||| VBN
recently  ||| S:459 E:468 ||| RB
increased  ||| S:468 E:478 ||| VBN
due  ||| S:478 E:482 ||| JJ
to  ||| S:482 E:485 ||| TO
their  ||| S:485 E:491 ||| PRP$
broad-spectrum  ||| S:491 E:506 ||| JJ
antimicrobial  ||| S:506 E:520 ||| JJ
activities  ||| S:520 E:531 ||| NNS
including  ||| S:531 E:541 ||| VBG
antibacterial ||| S:541 E:554 ||| NN
,  ||| S:554 E:556 ||| ,
antifungal ||| S:556 E:566 ||| NN
,  ||| S:566 E:568 ||| ,
antiviral ||| S:568 E:577 ||| JJ
,  ||| S:577 E:579 ||| ,
anti-settlement ||| S:579 E:594 ||| NNP
,  ||| S:594 E:596 ||| ,
antiprotozoan ||| S:596 E:609 ||| NN
,  ||| S:609 E:611 ||| ,
antiparasitic ||| S:611 E:624 ||| NN
,  ||| S:624 E:626 ||| ,
and  ||| S:626 E:630 ||| CC
antitumor ||| S:630 E:639 ||| NN
.  ||| S:639 E:641 ||| .
These  ||| S:641 E:647 ||| DT
allelochemicals  ||| S:647 E:663 ||| NN
not  ||| S:663 E:667 ||| RB
only  ||| S:667 E:672 ||| RB
provide  ||| S:672 E:680 ||| VB
protection  ||| S:680 E:691 ||| NN
to  ||| S:691 E:694 ||| TO
host  ||| S:694 E:699 ||| VB
from  ||| S:699 E:704 ||| IN
other  ||| S:704 E:710 ||| JJ
surrounding  ||| S:710 E:722 ||| VBG
pelagic  ||| S:722 E:730 ||| JJ
microorganisms ||| S:730 E:744 ||| NN
,  ||| S:744 E:746 ||| ,
but  ||| S:746 E:750 ||| CC
also  ||| S:750 E:755 ||| RB
ensure  ||| S:755 E:762 ||| VB
their  ||| S:762 E:768 ||| PRP$
association  ||| S:768 E:780 ||| NN
with  ||| S:780 E:785 ||| IN
the  ||| S:785 E:789 ||| DT
host ||| S:789 E:793 ||| NN
.  ||| S:793 E:795 ||| .
Antimicrobial  ||| S:795 E:809 ||| JJ
compounds  ||| S:809 E:819 ||| NN
from  ||| S:819 E:824 ||| IN
marine  ||| S:824 E:831 ||| JJ
sources  ||| S:831 E:839 ||| NNS
are  ||| S:839 E:843 ||| VBP
promising  ||| S:843 E:853 ||| VBG
and  ||| S:853 E:857 ||| CC
priority  ||| S:857 E:866 ||| NN
targets  ||| S:866 E:874 ||| NNS
of  ||| S:874 E:877 ||| IN
biotechnological  ||| S:877 E:894 ||| NN
and  ||| S:894 E:898 ||| CC
pharmaceutical  ||| S:898 E:913 ||| JJ
applications ||| S:913 E:925 ||| NNS
.  ||| S:925 E:927 ||| .
This  ||| S:927 E:932 ||| DT
review  ||| S:932 E:939 ||| NN
describes  ||| S:939 E:949 ||| VBZ
the  ||| S:949 E:953 ||| DT
bioactive  ||| S:953 E:963 ||| JJ
metabolites  ||| S:963 E:975 ||| NN
reported  ||| S:975 E:984 ||| VBD
from  ||| S:984 E:989 ||| IN
seaweed-associated  ||| S:989 E:1008 ||| JJ
bacterial  ||| S:1008 E:1018 ||| NN
and  ||| S:1018 E:1022 ||| CC
fungal  ||| S:1022 E:1029 ||| JJ
communities  ||| S:1029 E:1041 ||| NNS
and  ||| S:1041 E:1045 ||| CC
illustrates  ||| S:1045 E:1057 ||| VBZ
their  ||| S:1057 E:1063 ||| PRP$
bioactivities ||| S:1063 E:1076 ||| NN
.  ||| S:1076 E:1078 ||| .
Biotechnological  ||| S:1078 E:1095 ||| JJ
application  ||| S:1095 E:1107 ||| NN
of  ||| S:1107 E:1110 ||| IN
metagenomic  ||| S:1110 E:1122 ||| JJ
approach  ||| S:1122 E:1131 ||| NN
for  ||| S:1131 E:1135 ||| IN
identifying  ||| S:1135 E:1147 ||| VBG
novel  ||| S:1147 E:1153 ||| NN
bioactive  ||| S:1153 E:1163 ||| NN
metabolites  ||| S:1163 E:1175 ||| NN
is  ||| S:1175 E:1178 ||| VBZ
also  ||| S:1178 E:1183 ||| RB
dealt ||| S:1183 E:1188 ||| VBN
,  ||| S:1188 E:1190 ||| ,
in  ||| S:1190 E:1193 ||| IN
view  ||| S:1193 E:1198 ||| NN
of  ||| S:1198 E:1201 ||| IN
their  ||| S:1201 E:1207 ||| PRP$
future  ||| S:1207 E:1214 ||| JJ
development  ||| S:1214 E:1226 ||| NN
as  ||| S:1226 E:1229 ||| IN
a  ||| S:1229 E:1231 ||| DT
strong  ||| S:1231 E:1238 ||| JJ
tool  ||| S:1238 E:1243 ||| NN
to  ||| S:1243 E:1246 ||| TO
discover  ||| S:1246 E:1255 ||| VB
novel  ||| S:1255 E:1261 ||| JJ
drug  ||| S:1261 E:1266 ||| NN
targets  ||| S:1266 E:1274 ||| NNS
from  ||| S:1274 E:1279 ||| IN
seaweed-associated  ||| S:1279 E:1298 ||| JJ
microbial  ||| S:1298 E:1308 ||| JJ
communities ||| S:1308 E:1319 ||| NNS
.  ||| S:1319 E:1321 ||| .
